ICCC — ImmuCell Corporation
$10.75
+$0.56 (+5.44%)
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis.
Market Cap
$97.63M
Forward P/E
-97.7x
52-Week Range
N/A
ICCC Price History
Revenue vs. Net Income
$15.3M
Revenue · FY2020
Annual. Net margin is shown under each year.
Free Cash Flow
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
